Rekvina Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	134	-	27	27	27	24
Market Cap Growth	229.88%	-	-	-	13.35%	-4.80%
Enterprise Value	143	-	27	27	27	23
Last Close Price	22.30	-	4.50	4.50	4.50	3.97
PS Ratio	24.81	-	-	-	-	-
PB Ratio	-17.86	-	-13.90	205.50	194.94	25.73
P/TBV Ratio	-	-	-	205.50	194.94	25.73
P/OCF Ratio	-	-	-	274.00	-	-
EV/Sales Ratio	26.31	-	-	-	-	-
Debt / Equity Ratio	-1.08	-0.74	-0.20	6.16	-	-
Net Debt / Equity Ratio	-1.08	-0.67	-0.15	5.42	-0.03	-0.02
Quick Ratio	-	0.07	0.05	0.05	0.00	0.01
Current Ratio	-	0.09	0.05	0.05	0.00	0.06
Return on Equity (ROE)	-	-	-	-5.16%	-147.56%	-51.20%
Return on Assets (ROA)	-	-408.04%	-9.71%	-1.30%	-21.70%	-15.34%
Return on Invested Capital (ROIC)	-410.75%	-	-	-4.57%	-144.56%	-54.03%
Return on Capital Employed (ROCE)	-	41.30%	8.40%	-31.10%	-542.60%	-68.80%
Earnings Yield	-1.76%	-	-0.60%	-0.03%	-2.91%	-2.67%
Buyback Yield / Dilution	-0.41%	-	-	0.66%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.